Cargando…

OA08 A case of Recalcitrant Psoriatic Disease- should new treatment strategies be considered?

INTRODUCTION/BACKGROUND: Despite the advent of numerous biologic therapies and small molecular drugs targeting specific immune pathways, at least 40% of PsA patients exhibit poor response. Given the complexity and heterogeneity of signalling pathways resulting in synovio-entheseal disease in PsA; ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundanum, Sonia, Gorman, Áine, Veale, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515840/
http://dx.doi.org/10.1093/rap/rkac066.008